Keyphrases
Renal Cell Carcinoma
100%
BRCA2
91%
Ovarian Cancer
89%
Breast Cancer Susceptibility Gene 1 (BRCA1)
78%
BRCA2 mutation
47%
Breast Cancer
46%
Breast Cancer Risk
39%
Mutation Carriers
39%
BRCA mutation
36%
BRCA1, BRCA2
33%
Tumor Suppressor Gene
31%
Penetrance
28%
Germline mutation
27%
Germ Cells
27%
Methylation Analysis
27%
Cancer Risk
26%
Chromosome 3
26%
Clinical Genetics
25%
Genetic Testing
25%
Renal Tumor
25%
Breast
24%
High Risk
23%
Tumor Risk
23%
Pheochromocytoma
23%
First-degree Relatives
21%
Risk Phenotypes
21%
Proteotyping
21%
Tumor Genotyping
21%
Phenocopy
21%
Segregation Analysis
21%
Translocation Carrier
21%
Cancer Burden
21%
Clinical Genetic Services
21%
Clinical Features
21%
Von Hippel-Lindau
21%
SDHB mutation
21%
Carbohydrate Antigen 125 (CA125)
21%
Population Risk
21%
Conventional Renal Cell Carcinoma
21%
Transvaginal Ultrasound
21%
Clear Cell
21%
Modifier Genes
21%
Mutation Analysis
21%
Service Setting
21%
Succinate Dehydrogenase B
21%
Life Expectancy
21%
Genotype-phenotype
21%
Novel Genes
21%
Tumor Predisposition
21%
CpG Island Methylation
21%
Population Survey
21%
Late-onset
21%
Kindred
19%
Head-and-neck
19%
Neck Paragangliomas
19%
Family Risk
13%
Family History
13%
OVOL1
12%
Lifetime Risk
12%
Succinate Dehydrogenase B mutation
12%
Ovarian Cancer Risk
12%
Familial Breast Cancer
9%
Birt-Hogg-Dubé Syndrome
9%
Nonsyndromic
9%
Immunohistochemistry
9%
Kaplan-Meier Analysis
8%
Proband
8%
Carcinoma Cell Lines
8%
Anchorage-independent Growth
8%
Methylation
8%
Somatostatin
8%
C-Myc
8%
Renal Carcinoma Cells
8%
FBXW7
8%
FLCN Gene
8%
Cancer Registry
6%
Danish Population
6%
BRCAness
6%
Von Hippel-Lindau Disease
6%
Genetic Features
6%
In Situ Hybridization
6%
Second Analysis
5%
Carrier Status
5%
Retrospective Audit
5%
Risk Group 4
5%
First Degree
5%
Unaffected Relatives
5%
Family Testing
5%
Cohort Effect
5%
NHS Trusts
5%
Moderate Risk
5%
High-risk Population
5%
Ovarian Cancer Screening
5%
Genetic Services
5%
Birth Cohort
5%
With Woman
5%
Cumulative Risk
5%
Large Families
5%
Biochemistry, Genetics and Molecular Biology
BRCA2
90%
BRCA1
85%
Germ Cell
42%
Germline
42%
SDHB
42%
Chromosome Translocation 3
34%
Penetrance
34%
Genetics
33%
Tumor Suppressor Gene
32%
Germline Mutation
30%
Methylation
26%
Genetic Screening
24%
Fumarate Reductase
24%
Succinate Dehydrogenase
24%
Von Hippel-Lindau Disease
21%
Phenocopy
21%
Life Expectancy
21%
Cancer Genetics
21%
Modifier Gene
21%
CpG Island
21%
Genotyping
21%
Ubiquitin-Conjugating Enzyme
14%
FBXW7
14%
Cytogenetics
13%
Promoter Region
11%
Anchorage Independent Growth
11%
Messenger RNA
11%
Autosomal Dominant Inheritance
10%
Chromosome 3
9%
Proband
9%
Oncogene C Myc
8%
Somatostatin
8%
F-Box Protein
7%
Cysteine
7%
Gene Deletion
7%
Retrospective Study
7%
Chromosome 5
7%
Mammalian Target of Rapamycin
7%
Active Site
7%
SDHD
6%
Lifespan
6%
Cancer Registry
6%
Cancer Incidence
5%
Fluorescence in Situ Hybridization
5%